Clinical Trials on Hyperphenylalaninemia, Non-Phenylketonuric in Poland

Total 1437 results

BioMarin Pharmaceutical

Completed

Safety and Efficacy Study of Phenoptin in Subjects With Hyperphenylalaninemia Due to BH4 Deficiency

Tetrahydrobiopterin Deficiencies | Hyperphenylalaninemia, Non-Phenylketonuric

Germany, United States
BioMarin Pharmaceutical

Completed

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry (PKUDOS)

Phenylketonuria | Hyperphenylalaninaemia

United States
Washington University School of Medicine
University of Missouri-Columbia; Northwestern University; Oregon Health and Science... and other collaborators

Terminated

Behavioral Effects of Kuvan in Children With Mild Phenylketonuria

Phenylketonuria

United States
BioMarin Pharmaceutical

Recruiting

A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace) (PALace)

Phenylketonuria (PKU)

United States, Germany, Italy
BioMarin Pharmaceutical

Completed

Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU

Phenylketonuria (PKU)

United States
BioMarin Pharmaceutical

Completed

Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU (Prism-2)

Phenylketonuria (PKU)

United States
Oregon Health and Science University

Terminated

Moderate Intensity Exercise and Phenylketonuria

Phenylketonuria | PKU

United States
Vitaflo International, Ltd
Oregon Health and Science University

Completed

Evaluation of PKU Sphere

Phenylketonurias

United States
BioMarin Pharmaceutical

Completed

A Phase 3 Substudy to Evaluate Executive Function in Adults With PKU Who Are Participating in the Phase 3 Study, 165-302 (PRISM303)

Phenylketonuria

United States
BioMarin Pharmaceutical

Completed

Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria

Phenylketonuria

United States
BioMarin Pharmaceutical

Completed

Dose-Finding Study to Evaluate the Safety, Efficacy, & Tolerability of Multiple Doses of rAvPAL-PEG in Subjects With PKU

Phenylketonuria

United States
Synlogic

Completed

Efficacy and Safety of SYNB1618 and SYNB1934 in Adult Patients With Phenylketonuria (SynPheny-1)

Phenylketonuria

United States
BioMarin Pharmaceutical

Completed

Long-Term Extension of Previous rAvPAL-PEG Protocols in Subjects With PKU (PAL-003)

Phenylketonuria

United States
BioMarin Pharmaceutical

Completed

Study to Evaluate the Safety and Efficacy of Phenoptin™ in Subjects With Phenylketonuria Who Have Elevated Phenylalanine Levels

Phenylketonurias

United States
BioMarin Pharmaceutical

Completed

Study to Evaluate the Response to and Safety of an 8-Day Course of Phenoptin™ Treatment in Subjects With Phenylketonuria

Phenylketonurias

United States
BioMarin Pharmaceutical

Completed

A Prospective Clinical Study of Phenylketonuria (PKU)

Phenylketonurias

United States
BioMarin Pharmaceutical

Completed

A Phase 3, Multicenter, Open-Label Extension Study of Phenoptin in Subjects With PKU Who Have Elevated Phenylalanine Levels

Phenylketonurias

United States
BioMarin Pharmaceutical

Completed

Study of Phenoptin in Subjects With Phenylketonuria Who Participated in Protocols PKU-004 or PKU-006

Phenylketonuria

United States
Jnana Therapeutics

Recruiting

First-in-Human, Multiple Part Clinical Study of JNT-517 in Healthy Participants and in Participants With Phenylketonuria

Phenylketonuria

United States, Australia
Synlogic

Terminated

Efficacy and Safety of SYNB1934 in Patients With PKU (SYNPHENY-3) (SYNPHENY-3)

Phenylketonuria

United States, Canada, Georgia, Turkey
BioMarin Pharmaceutical

Completed

An Open-Label Phase 3 Study of BMN 165 for Adults With PKU Not Previously Treated w/ BMN 165 (Prism301)

Phenylketonuria

United States
BioMarin Pharmaceutical

Completed

Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients

Phenylketonuria

United States, Canada
Poznan University of Medical Sciences

Recruiting

Effect of Probiotics or Berberine in Hepatic Steatosis Markers, Cardiometabolic and Microbiotic Profile in NAFL.

Obesity | Non Alcoholic Fatty Liver

Poland
Pulmonary Hospital Zakopane

Completed

Comparison of Diagnostic and Therapeutic Efficacy of EBUS-TBNA/EUS-FNA and TEMLA in Operable NSCLC.

Non-small Cell Lung Cancer

Poland
Independent Public Care Health Facility of the...

Unknown

Hypofractionated Accelerated Radiotherapy With Concomitant Chemotherapy for NSCLC

Non-small Cell Lung Cancer

Poland
Oncozyme Pharma Inc.

Completed

An Exploratory Study of OCZ103-OS in Combination With Standard of Care in Stage IV Non-Small Cell Lung Cancer (NSCLC) Patients

Non-small Cell Lung Cancer

Poland
Pomeranian Medical University Szczecin
Humboldt-Universität zu Berlin

Completed

Functional Roll for Non-alcoholic Fatty Liver Disease (NAFLDroll)

Non-Alcoholic Fatty Liver Disease

Poland
Pulmonary Hospital Zakopane

Recruiting

Comparison of Two Techniques of Uniportal VATS Lobectomies for Clinical Stage I Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer (NSCLC) | Video Assisted Thoracic Surgery (VATS)

Poland
Ardigen
Małopolskie Centre of Entrepreneurship

Unknown

AImmune - Artificial Intelligence Algorithm for Identification of Immunogenic Neoepitopes of Cancer to Predict and Boost Patient's Response to Immunotherapies.

Non Small Cell Lung Cancer | Immunotherapy | Neoantigens | Neoepitopes | Next Generation Sequencing (NGS) | Personalized Neoantigen Cancer Vaccine

Poland
Maria Sklodowska-Curie National Research Institute...

Unknown

Randomized Trial of G-CSF Alone Versus Intermediate-dose Ara-C Plus G-CSF Mobilization in Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma

Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma

Poland
Medical University of Gdansk
Pharmacia; Central and Eastern European Oncology Group; Stowarzyszenie Ludzi...

Suspended

Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients

Non-Small Cell Lung Cancer

Poland
Academisch Medisch Centrum - Universiteit van Amsterdam...

Unknown

Complete Endosonographic Intrathoracic Nodal Staging of Lung Cancer Patients in Whom SABR is Considered

Non Small Cell Lung Cancer (NSCLC) | Intrathoracic Nodal Staging

Netherlands, Poland
Maria Sklodowska-Curie National Research Institute...
Medical University of Gdansk; The Greater Poland Cancer Centre; Medical University... and other collaborators

Completed

Prospective Study of Quality of Life in Non-small Cell Lung Cancer (NSCLC) Patients Treated With/Without Postoperative Radiotherapy

Non-Small Cell Lung Cancer

Poland
Perspectum
Children's Memorial Health Institute, Poland

Completed

Assessing Kids for Liver Inflammation and Fibrosis Using Non-invasive MRI (Kids4LIFe)

Liver Diseases | Autoimmune Hepatitis | Liver Cirrhoses | Non-alcoholic Steatohepatitis | Liver Fibroses

Poland
Helix BioPharma Corporation
Pharm-Olam International

Completed

A Phase I/II Open-Label, Non-Randomized Dose Escalation Study of Immunoconjugate L-DOS47

Non-Small Cell Lung Cancer

Poland
Medical University of Silesia

Completed

Clinical Effects of Eptifibatide Administration in High Risk Patients Presenting With Non-ST Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Urgent Coronary Artery Bypass Graft Surgery in Short- and Long-Term Follow-up

Non ST Elevation Myocardial Infarction

United States, Poland
Military Institute of Medicine, Poland

Recruiting

Radiation-induced Cardiac Toxicity After Non-small Cell Lung Cancer Radiotherapy

Non-small Cell Lung Cancer | Radiation Toxicity | Cardiac Toxicity

Poland
Medical University of Bialystok
National Science Centre, Poland

Completed

Effects of Different Omeprazole Dosing on Gastric pH in Non-variceal Upper Gastrointestinal Bleeding

Non-variceal Upper Gastrointestinal Bleeding

Poland
Eli Lilly and Company

Completed

Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes

Non-Small Cell Lung Cancer

Poland
Nicolaus Copernicus University

Completed

The Evaluation of Vitiligous Lesions Repigmentation After Topical Administration of Methotrexate in Patients With Active Vitiligo (EVRAM)

Non-segmental Vitiligo

Poland
Nicolaus Copernicus University

Completed

The Evaluation of Vitiligous Lesions Repigmentation After the Administration of Atorvastatin Calcium Salt and Simvastatin-acid Sodium Salt in Patients With Active Vitiligo (EVRAAS)

Non-segmental Vitiligo

Poland
Wroclaw Medical University

Completed

Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer

Recurrence | Progression | Biomarkers | Bladder Cancer | Non-muscle Invasive Bladder Cancer | Cystoscopy

Poland
Affimed GmbH

Terminated

Safety Study to Assess AFM11 in Patients With Relapsed and/or Refractory CD19 Positive B-cell NHL

Refractory B-Cell Non-Hodgkin Lymphoma | Relapsed B-Cell Non-Hodgkin Lymphoma

United States, Czechia, Germany, Poland
Polish Lymphoma Research Group
Roche Pharma AG

Terminated

Efficacy and Safety of Obinutuzumab Preemptive Treatment at the Time of the Molecular Relapse (OPERA-PLRG10)

Mantle Cell Lymphoma

Poland
MedImmune LLC

Terminated

A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Patients With Non-Hodgkin's Lymphoma (NHL)

Lymphoma

United States, Poland
Academisch Medisch Centrum - Universiteit van Amsterdam...

Recruiting

Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitis (SYNCH)

Probiotics | Non-Alcoholic Fatty Liver Disease | Microbiome | Gut Microbiome | Fecal Microbiota Transplantation | Intestinal Microbiome | FMT | Non Alcoholic Steatohepatitis | Prebiotics

Netherlands
Central European Cooperative Oncology Group

Terminated

Phase II Trial of Dose-dense Paclitaxel and Cisplatin as Neo-adjuvant Chemotherapy for Operable Stage II and IIA NSCLC

Non-Small Cell Lung Cancer

Austria, Hungary, Poland
Collegium Medicum w Bydgoszczy

Not yet recruiting

Prasugrel Or Ticagrelor De-escalation in NSTE-ACS (PROTEUS)

Unstable Angina | Non ST Segment Elevation Acute Coronary Syndrome | Non-ST-Segment Elevation Myocardial Infarction (NSTEMI)

Poland
Physio-Assist
Medical University of Lodz; University Hospital in Krakow

Recruiting

Simeox Therapy at Home Versus Standard of Care in NCFB Patients With CMH

Non-cystic Fibrosis Bronchiectasis | Chronic Mucus Hypersecretion

Poland
Providence Health & Services
Bristol-Myers Squibb; Genentech, Inc.

Terminated

Trial of Bevacizumab and Ixabepilone for Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

Non-squamous Non-small Cell Lung Cancer

United States

Clinical Trials on Hyperphenylalaninemia, Non-Phenylketonuric in Poland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations